A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas Article

Kumthekar, Priya, Grimm, Sean, Chandler, James et al. (2017). A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas . JOURNAL OF NEURO-ONCOLOGY, 133(3), 589-594. 10.1007/s11060-017-2469-x

cited authors

  • Kumthekar, Priya; Grimm, Sean; Chandler, James; Mehta, Minesh; Marymont, Maryanne; Levy, Robert; Muro, Kenji; Helenowski, Irene; McCarthy, Katie; Fountas, Leanne; Raizer, Jeffrey

sustainable development goals

authors

publication date

  • July 1, 2017

webpage

published in

keywords

  • Anaplastic astrocytoma
  • Arsenic
  • Arsenic trioxide
  • CELLS
  • Clinical Neurology
  • GBM
  • GLIOBLASTOMA RESISTANCE
  • Glioma
  • Life Sciences & Biomedicine
  • MECHANISMS
  • Neurosciences & Neurology
  • Oncology
  • RADIOTHERAPY
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 589

end page

  • 594

volume

  • 133

issue

  • 3